Ledger.Open graph →
SEC Form D · filed April 24, 2019

ADASTRA PHARMACEUTICALS, INC

Offering
$12.0M
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Eckard R. Weber · SAN DIEGO, CADirectorDennis M. Podlesak · SAN DIEGO, CADirectorThomas M. Estok · Baltimore, MDDirectorMauro Bove · Rockville, MDDirectorAlain R. Schreiber · SAN DIEGO, CADirectorLynne R. Rollins · SAN DIEGO, CAExecScott M. Megaffin · SAN DIEGO, CAExec · DirectorTracy M. Lawhon · SAN DIEGO, CAExecGrigory Borisenko · SAN DIEGO, CADirectorChris E. Christoffersen · SAN DIEGO, CADirectorLynne R. Rollins · SAN DIEGO, CAExecEckard R. Weber · SAN DIEGO, CADirectorDennis M. Podlesak · SAN DIEGO, CADirectorScott M. Megaffin · SAN DIEGO, CAExec · DirectorTracy M. Lawhon · SAN DIEGO, CAExecThomas M. Estok · San Diego, CADirectorMauro Bove · Rockville, MDDirectorGrigory Borisenko · SAN DIEGO, CADirectorChris E. Christoffersen · SAN DIEGO, CADirectorAlain R. Schreiber · SAN DIEGO, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗